Eisai
4523.T
#2159
Rank
โ‚น845.08 B
Marketcap
โ‚น2,998
Share price
1.81%
Change (1 day)
20.75%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): โ‚น73.02

According to Eisai's latest financial reports the company's current EPS (TTM) is โ‚น78.75. an increase over its 2024 EPS that were of โ‚น88.78.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025โ‚น99.3011.85%
2024โ‚น88.78-32.63%
2023โ‚น131.795.52%
2022โ‚น124.89-74.01%
2021โ‚น480.49-66.58%
2020โ‚น1,43898.24%
2019โ‚น725.1317.01%
2018โ‚น619.7137.78%
2017โ‚น449.80-27.62%
2016โ‚น621.4535.33%
2015โ‚น459.21-2.82%
2014โ‚น472.55-27.66%
2013โ‚น653.27-27.49%
2012โ‚น900.98-12.67%
2011โ‚น1,03288.08%
2010โ‚น548.57-11.06%
2009โ‚น616.80-390.15%
2008-โ‚น212.58-127.78%
2007โ‚น765.3411.78%
2006โ‚น684.704.38%
2005โ‚น655.997.4%
2004โ‚น610.8243.03%
2003โ‚น427.0725.09%
2002โ‚น341.4052.67%
2001โ‚น223.6269.76%
2000โ‚น131.73